Molybdenum cofactor deficiency (MoCD) is a rare autosomal recessive disorder that may present during the neonatal period with intractable seizures. Co-existence of MoCD and pyloric stenosis is previously reported as a coincidence or common etiology. The etiology of the two conditions is unclear; however, reports demonstrate neuronal deficiency in both. We report a neonate who was diagnosed with MoCD and hypertrophic pyloric stenosis.
Introduction
Molybdenum cofactor deficiency (MoCD) is a rare, autosomalrecessive fatal disease, leading to a combined deficiency of the enzymes sulfite oxidase (SOD), xanthine dehydrogenase and aldehyde oxidase. Since the first description by Duran et al.,
1 more than 100 patients have been diagnosed with MoCD from diverse ethnic groups. The clinical presentation is usually in the first days of life, with feeding difficulties, vomiting and seizures. The disease has resulted in death in B75% of the neonatal-onset cases, usually in infancy. 2 Diagnosis is based on a sulfite strip test and absent SOD activity in skin or liver fibroblast culture. 3 Currently, substitution of purified cyclic pyranopterin monophosphate represents the first causative therapy available for patients with MoCD. 4 Pyloric stenosis usually presents with non-bilious projectile vomiting during the third to fourth week of life. It is now clear that pyloric stenosis is caused by the selective inadequate development of inhibitory neurons in the myenteric plexus of the pyloric region that utilize vasoactive intestinal polypeptide and nitric oxide (NO) as neurotransmitters to relax the sphincter. 5 In general, it is accepted that in MoCD damage to the neural tissue possibly results from a toxic effect of sulfite accumulation.
Low uric acid concentration will allow for accumulation of reactive oxyradicals, which may contribute to neurological damage. 6 The presence of neurological damage and abnormal innervations provides a potential etiological link between these two diseases. To our knowledge, Currie and Gains 7 first reported this coincidence as a case presentation and Pedro et al. 8 reported this as a slide-in-slide session. We also suspect a potential etiological link between these two conditions and reported on a neonate who was diagnosed with MoCD and hypertrophic pyloric stenosis (HPS).
Case
The neonate was the second child of non-consanguineous, healthy parents. No history of maternal disease in pregnancy was elicited. He was born after an unremarkable pregnancy and labor at 40 weeks of gestation. The first child of the family, a 2-year-old girl, is healthy. Apgar scores were 8 and 10 at 1 and 5 min, respectively. Birth weight was 3740 g (50th to 90th percentile), birth height was 49 cm (10th to 50th percentile) and head circumference was 37.8 cm (90th to 97th percentile). He had a coarse face and hypotonia. He required mechanical ventilation shortly after birth. Later on he had intractable seizures. Seizures were controlled by phenobarbital and phenytoin.
Initial laboratory results were normal, including complete blood count, urine analysis, blood urea, creatinine, electrolytes, liver function tests, serum proteins and lipids, and blood glucose. In terms of metabolic screening, blood pH, ammonia, lactic and pyruvic acid levels, urinary orotic acid, and urinary and blood amino-acid levels revealed normal results. An extremely low plasma uric acid level (0.5 and 0.1 mg dl
À1
, respectively) and a positive urinary sulfite strip test led us to suggest MoCD. We identified a mutation in the MOCS2 gene. The diagnosis of MoCD was considered, because of intractable seizures, low blood uric acid levels, positive urine sulfite stick test and mutation in the MOCS2 gene. The enzyme activity could not be measured. Cranial ultrasound demonstrated the presence of dilated ventricles. Magnetic resonance imaging of the brain revealed striking abnormalities: hypoplasia of the cerebellar hemispheres and vermis were detected. There were diffusion restriction and edema in the supratentorial cerebral cortex, caudate nuclei, mesencephalon and crus cerebri location. Ophthamological examination did not show lens dislocation.
The patient started vomiting at about 1 month of age. Abdominal examination showed a small palpable mass in the epigastrium. Direct abdominal radiography showed gastric dilatation (Figure 1 ). Blood gas analyses showed that metabolic alkalosis (pH: 7.44, PCO 2 : 45, PO 2 : 73, HCO 3 : 32). Further evaluation with a 12-MHz linear array transducer showed the pyloric wall thickened at 5 mm, the pyloric canal was measuring 19 mm and abdominal ultrasound confirmed the diagnosis of HPS and underwent pyloromyotomy (Figure 2) . He was started feeding on first postoperative day.
At the follow-up, at 8 months of age, he revealed psychomotor delay with no head control, no language development and spasticity. He has not developed lens dislocation so far.
Discussion
Molydenum-containing cofactor is essential for the function of SOD, xanthine dehydrogenase and aldehyde oxidase. The clinical picture appears to be similar in isolated SOD deficiency and molybdenum cofactor deficiency. Affected individuals, in the newborn period or early infancy, typically display intractable seizures, metabolic acidosis, intracranial hemorrhage, feeding difficulties, disordered autonomic function, exaggerated startle reactions, dysmorphic facial features, profound developmental delay, alterations in muscle tone, progressive cerebral palsy, abnormal tone, microcephaly, lens dislocation and renal stones. Approximately 75% of infants exhibit facial dysmorphism as puffy cheeks, small nose, long philtrum and coarse facial features. A course involving progression to spasticity, severe mental retardation and microcephaly occurs in survivors. Dislocated lenses and a seborrheic rash appear later in infancy, but dislocated lenses have been observed as early as at 2 months of age. 2, 3 Our patient presented feeding difficulty and resistant convulsion on his first day.
The diagnosis should be considered in the newborn with seizures of unknown origin; a sulfite strip test on a fresh urine sample is a simple screening procedure. Detection of hypouricemia thus is a second valuable and simple screening test. 2, 3, 6 Our patient screening tests showed low uric acid and positive sulfite strip test, but a deficiency of MoCD couldn't be confirmed MoCD in cultured fibroblast. His genetic analyses confirmed our diagnosis mutation in MoCD2 gene.
HPS is the most common surgical cause of vomiting in infants. With HPS, the pyloric muscle is enlarged and the pyloric channel becomes elongated. 10 The infant presents in the first 2 and 12 weeks of life. The incidence of HPS has been reported to be B3 per 1000 live births. 11, 12 The diagnosis is initially suggested by the history. Palpation of a hypertrophied pyloric muscle, or '' olive'', is diagnostic and successful in the majority of infants with a 99% positive predictive value. Treatment of HPS is a pyloromyotomy.
Although several potentially causative factors have been explored, the pathogenesis of HPS is not yet fully understood. Despite remaining questions, considerable progress has been made in the recent years, especially in the areas of genetics and pyloric innervations. Increasing evidence suggests that in HPS there are quantitative or qualitative abnormalities in the innervations of smooth muscle cells. 11 NO is a gaseous free radical that is synthesized, and reduction in the amount of the NO caused failure of pyloric relaxation in the enteric nervous system. Reduced nitrous oxide systems activity has been reported in the muscular layer of hypertrophic pyloric stenotic sample. 7, 11 NO production can still be achieved through a pathway involving the molybdenum dependent enzyme, xanthine oxidase. 7, 13 Review of the literature reported two cases of HPS with MoCD. In-patient with MoCD and SOD, alternative NO production pathway may also be disrupted, predisposing the patient to a reduced level of NO and potentially to pyloric stenosis. Also decreased NO production may potentially role in IHPS. Toxic accumulation of sulfite in cerebral white matter and long tracts in the spinal cord may affect other neuronal channels, such as those of the myenteric plexus on enteric system. This neuronal toxicity could result in abnormal innervations of the muscle layer, failure of relaxation of the pyloric muscle and subsequent hypertrophy, hyperplasia and obstruction. A more likely link between SOD/ MoCD and pyloric stenosis is through toxicity to the nervous system. 7 There are insufficient data to determine a clear link between pyloric stenosis and SOD or MoCD. More new patients will need to be examined between these two conditions to clearly understand pathogenesis. However, both conditions may be coincidental. Other described cases with SOD and MoCD and our case highlights the importance of increased awareness of the possible coexistence of these disorders.
Although diagnosis is a metabolic disorder in vomiting patients, anatomic defect such as pyloric stenosis should always be in mind.
